An apple a day is as effective as statins at preventing vascular death
They found that people who drank at least one diet soft drink every day were at a 43% higher risk for stroke, heart attack, and vascular death
than those who drank from none to six a week.
NEW ORLEANS - An elevated Framingham Risk Score identified recent ischemic stroke patients at high risk for a myocardial infarction or vascular death
over the next 2 years, in a retrospective analysis of data from more than 2,500 stroke survivors without documented coronary heart disease.
Washington, Feb 1 ( ANI ): Individuals who drink diet soft drinks on a daily basis may be at increased risk of suffering vascular events such as stroke, heart attack, and vascular death
, a new study has warned.
As stated previously a diagnosis of PAD is significantly correlated with a higher morbidity and mortality The Pandora study conducted by Cimminiello et al, revealed in patients without overt cardiovascular disease the presence of PAD predicts approximately a 30% risk of myocardial infarction, ischemic stroke, and vascular death
within five years of diagnosis This study also revealed that study participants (26%) were less informed about PAD as compared to those who reported some information related to stroke (74%) and coronary artery disease (67%).
A separate analysis of diet soda intake among many of the same individuals found that having at least one diet soda a day was associated with nearly a 50% increase in the risk of stroke, myocardial infarction, or vascular death
, compared with people who did not drink soda at all.
Whereas the incidence rates of MI and nonstroke vascular death
are only about 1% per year, the risk rises in patients with additional CAD to 2 to 2.
Results showed that those with the highest levels of Lp-PLA2 had an increased risk of recurrent stroke, heart attack, or vascular death
, even after adjusting for factors such as age, sex, ethnicity, and history of heart disease.
On the other hand, we were unable to identify any association between anti-cardiolipin antibodies and vascular death
or noncancer mortality, including all causes of death except neoplasia.
The Clopidogrel versus Aspirin in Patients at Risk of Ischemic Event trial (CAPRIE) was a randomized, blinded trial designed to assess the relative efficacy of clopidogrel (75 mg once a day) and aspirin (325 mg once a day) in reducing a composite outcome of CVA, MI, or vascular death
The primary endpoint for the study was ipsilateral stroke, vascular death
, or study-related death at the end of one year.
The study results also showed that apixaban demonstrated superiority for its secondary efficacy endpoint in reducing the composite of stroke, systemic embolism, myocardial infarction or vascular death
for patients with AF when compared with aspirin.